The global stem cells market size is expected to reach USD 170.15 billion by 2020, according to a new report by Grand View Research, Inc. The market is expected to grow because of increasing research and development to develop therapeutic solution for chronic diseases and the huge funding by the government for drug discovery and development to serve the large unmet medical needs.
The WHO statistics on Cancer (2012) concluded that it is the leading cause for global mortality and morbidity, with around 14 million new cancer cases and 8.2 million cancer related deaths which is estimated to reach 22 million in next two decades. Stem cells in combination with gene therapy along with DNA repair is anticipated to be used to treat many intractable diseases and is classified under orphan drugs.
The California’s Stem Cell Agency has spent around USD 1.4 billion for stem cell research and still has USD 872 million to provide for the same. In addition to this, in 2013 the National Institute of Health has funded around USD1.3 million stem cell researches.
View
summary of this report @ http://www.grandviewresearch.com/industry-analysis/stem-cells-market
Further key findings from the report suggest:
·
Adult stem cell leads the market due to low
contamination during sub-culture and expansion, relatively low labor production
and compatibility with the human body. Induced pluripotent stem cells are
expected to report revenue of over USD 4.5 billion by 2020, on account of
analogous nature of its origin.
·
Different types of technologies include cell
acquisition, cryopreservation, cell production, expansion and sub-culture. For
any technique in stem cell production, stem cell acquisition is the basic step;
hence, this segment is likely to dominate the market with revenues estimated at
USD 10.9 billion by 2020.
·
Application of stem cell in regenerative
medicines is exponentially increasing and hence dominates the market as
compared to its application in drug discovery and medicine. Geographical
presence of stem cell market is in North America, Asia Pacific, Europe and rest
of the world. North America held the largest industry share due to huge
government funding and initiative for stem cell research and rise in the
acceptance of stem cell therapies.
·
However, Asia-Pacific is expected to be the
fastest growing segment with a CAGR of over 25.0% due to rising contract
research outsourcing and medical tourism. Key industry contributors include
Advanced Cell Technology Inc., CellartisAB, Cellular Engineering Technologies
Inc., BioTime Inc. and International Stem Cell Corporation.
·
In March 2015, International Stem Cell
Corporation received patent from Japan for it human cell bank production from
pathogenically activated eggs. This is in alignment with the companies’
strategy to make its intellectual property position strong and also develop
relationship with Japan. Moreover, in June 2015, Cellaris AB launched a new
xeno free culture called Cellartis EF-CS.
·
Factors such as government funding, key player
engagement to update the techniques, collaboration with domestic players for
country specific market entry are expected to boom the stem cell market.
Browse All Reports of
this category @ http://www.grandviewresearch.com/industry/biotechnology
Grand View Research has segmented
the global stem cells market on the basis of product, application, technology
and region:
Stem Cells Product Outlook
- Stem Cells Platforms
- Sequence Analysis Platforms
- Adult Stem Cells
- Hematopoietic Stem Cells
- Mesenchymal Stem Cells
- Neuronal Stem Cells
- Dental Stem Cells
- Umbilical Cord Stem Cells
- Human Embryonic Stem Cells
- Induced Pluripotent Stem Cells
- Natural Rosette Cells
- Very Small Embryonic Like Stem Cells
Stem Cells Application Outlook
- Regenerative Medicine
- Neurology
- Orthopedics
- Oncology
- Hematology
- Cardiovascular and Myocardial Infraction
- Injuries
- Diabetes
- Liver Disorder
- Incontinence
- Others (Crohn’s Disease, Infertility, Immunodeficiency Disorder, Organ Transplants, Ophthalmic Disorder)
- Drug Discovery and Development
Stem Cells Technology Outlook
- Cell Acquisition
- Bone Marrow Harvest
- Apheresis
- Umbilical Blood Cord
- Cell Production
- Therapeutic Cloning
- In Vitro Fertilization
- Isolation
- Cell Culture
- Cryopreservation
- Expansion and Sub-Culture
Stem Cells Regional Outlook
- North America
- Europe
- Asia Pacific
- RoW
About Grand View
Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, the
company offers market intelligence studies ensuring relevant and fact-based
research across a range of industries including technology, chemicals,
materials, healthcare and energy.
Contact:
Sherry
James
Corporate
Sales Specialist, U.S.A.
Grand
View Research, Inc.
United
States
Phone: 1-415-349-0058
Toll
Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Blog
Site: http://www.divog.org/
No comments:
Post a Comment